Search Filters. Trial Filters. A listing of Izmit, Turkey clinical trials actively recruiting patients volunteers. This is a multicenter, randomized, open-label, active-controlled Phase 3 study of the efficacy and safety of vadadustat versus darbepoetin alfa for the maintenance treatment of anemia in subjects with NDD-CKD.
This is an open-label the researchers and participants know the treatment the participant is receiving long-term extension study. This study designed to evaluate the long-term efficacy and safety of mirikizumab in participants with moderately to severely active ulcerative colitis UC. The purpose of this study is to evaluate the growth and compliance of an intended use population of infants receiving an extensively hydrolyzed infant formula.
The purpose of this study is to evaluate the safety and efficacy of Mirikizumab in participants with moderately to severely active ulcerative colitis UC who have had an inadequate response to, loss of response, or intolerant to conventional or biologic therapy for UC.
This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL on reducing the risk of major adverse CV events [MACE - cardiovascular CV death, myocardial infarction MI , and stroke] in subjects with acute coronary syndrome ACS diagnosed with either ST-segment elevation The objectives of this study are to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of PF mg for 8 weeks followed by 50 mg for 4 weeks dosed once daily and PF 60 mg for 12 weeks dosed once daily during an induction period of 12 weeks, followed The purpose of this study is to evaluate the efficacy and safety of mirikizumab as maintenance therapy in participants who completed prior week induction study AMAN NCT Powered by.
Search Medical Condition Please enter condition. Please choose location from dropdown. Within 10 mi about 15 km 25 mi about 40 km 50 mi about 80 km mi about km mi about km Entire World. Gender Male 1. Female 3. Both Study Type Interventional Observational 6. Trial Phase Phase 2 Phase 3 Phase 4 2.
